Invasion of human epithelial cells by Campylobacter upsaliensis.
Few data exist on the interaction of Campylobacter upsaliensis with host cells, and the potential for this emerging enteropathogen to invade epithelial cells has not been explored. We have characterized the ability of C. upsaliensis to invade both cultured epithelial cell lines and primary human small intestinal cells. Epithelial cell lines of intestinal origin appeared to be more susceptible to invasion than non-intestinal-derived cells. Of three bacterial isolates studied, a human clinical isolate, CU1887, entered cells most efficiently. Although there was a trend towards more efficient invasion of Caco-2 cells by C. upsaliensis CU1887 at lower initial inocula, actual numbers of intracellular organisms increased with increasing multiplicity of infection and with prolonged incubation period. Confocal microscopy revealed C. upsaliensis within primary human small intestinal cells. Both Caco-2 and primary cells in non-confluent areas of the infected monolayers were substantially more susceptible to infection than confluent cells. The specific cytoskeletal inhibitors cytochalasin B, cytochalasin D and vinblastine attenuated invasion of Caco-2 cells in a concentration-dependent manner, providing evidence for both microtubule- and microfilament-dependent uptake of C. upsaliensis. Electron microscopy revealed the presence of organisms within Caco-2 cell cytoplasmic vacuoles. C. upsaliensis is capable of invading epithelial cells and appears to interact with host cell cytoskeletal structures in order to gain entry to the intracellular environment. Entry into cultured primary intestinal cells ex vivo provides strong support for the role of host cell invasion during human enteric C. upsaliensis infection.
Mooney
Adele
A
Department of Paediatrics, The Conway Institute for Biomolecular and Biomedical Research, University College Dublin, The Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland.
Byrne
Catherine
C
Clyne
Marguerite
M
Johnson-Henry
Kathene
K
Sherman
Philip
P
Bourke
Billy
B
D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism; D044885:Campylobacter upsaliensis / Q000378:metabolism / Q000472:pathogenicity* / Q000648:ultrastructure; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D002648:Child; D003571:Cytochalasin B / Q000378:metabolism; D015638:Cytochalasin D / Q000378:metabolism; D003599:Cytoskeleton / Q000378:metabolism; D004705:Endocytosis / Q000502:physiology; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism / Q000382:microbiology*; D006801:Humans; D007422:Intestines / Q000033:anatomy & histology; D019384:Nucleic Acid Synthesis Inhibitors / Q000378:metabolism; D013997:Time Factors
D000972:Antineoplastic Agents, Phytogenic; D019384:Nucleic Acid Synthesis Inhibitors; D015638:Cytochalasin D; D003571:Cytochalasin B